
    
      Further secondary parameters are :

      Responders during at day 4 and 5, single symptom scores during 1 to 5 days of observation,
      pain at begin and end (100mm VAS), assessment of efficacy by physician and patient,
      consumption of rescue medication

      Assessment of safety by physician and patient, frequency of adverse events
    
  